MedTrace Logo

Comparison of Different Up-dosing Schedules With Osiris

NCT01240954 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2011-08-29

No results posted yet for this study

Summary

The purpose of this study is to compare different up-dosing schedules with Osiris.

Conditions

  • Allergic Rhinitis

Interventions

DRUG

OSIRIS

OSIRIS current practice

DRUG

OSIRIS other concentration 1

OSIRIS new concentration 1

DRUG

OSIRIS other concentration 2

OSIRIS new concentration 2

Sponsors & Collaborators

  • ALK-Abelló A/S

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01240954 on ClinicalTrials.gov